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A B S T R A C T
Aim. – To assess in women at high risk of gestational diabetes mellitus (GDM) the effect of a lifestyle
intervention on the metabolic health of their offspring around 5 years after delivery.
Methods. – For the original Finnish gestational diabetes prevention study (RADIEL), 720 women with a
prepregnancy body mass index (BMI)  30 kg/m2 and/or previous GDM were enrolled before or during
early pregnancy and allocated to either an interventional (n = 126) or conventional (n = 133) care group.
The present 5-year follow-up substudy assessed the metabolic health outcomes of their offspring. Age-
and gender-standardized residuals of metabolic health components (waist circumference, mean arterial
pressure, high-density lipoprotein and triglyceride levels, and fasting insulin/glucose ratio) were also
combined to determine the accumulation of metabolic effects. Body composition was assessed by
electrical bioimpedance.
Results. – Offspring of women in the intervention group had a less optimal metabolic profile after the
5-year follow-up compared with offspring in the usual care group (P = 0.014). This difference in
metabolic health was primarily related to lipid metabolism, and was more prominent among boys
(P = 0.001) than girls (P = 0.74). Neither GDM, gestational weight gain, prepregnancy BMI, offspring age
nor timing of randomization (before or during pregnancy) could explain the detected difference, which
was also more pronounced among the offspring of GDM pregnancies (P = 0.010). Offspring body
composition was similar in both groups (P > 0.05).
Conclusion. – The lifestyle intervention aimed at GDM prevention was associated with unfavourable
metabolic outcomes among offspring at around 5 years of age.
C 2019 Elsevier Masson SAS. All rights reserved.
Available online at
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The global rate of increase in obesity prevalence is now too high
to be explained solely by sedentary behaviours, unhealthy diets or
direct genetic factors [1]. For several years, the theory of
developmental programming has provided an additional explana-
tion for the trend. According to the Developmental origins of health
and disease (DOHaD) hypothesis, the association of unfavourable
intrauterine conditions related to, for example, maternal adiposity
[2], excessive gestational weight gain [3] and/or gestational
diabetes mellitus (GDM) [2,4] with adverse offspring outcomes
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DNA methylation and histone modifications [5]. However, the
question remains as to whether this information is of any use in
addressing the epidemic. Also, as the fetal environment is possibly
modifiable, lifestyle interventions before and during pregnancy
may be able to alter offspring health trajectories.
Many lifestyle interventions during pregnancy focused on the
reduction of GDM and its adverse outcomes have been conducted
but, in general, the results have been inconclusive [6–8]. To a large
extent, the effects of such interventions have been assessed
through health parameters in women and their offspring either
during pregnancy or the neonatal period. Only a few studies have
assessed the effect of GDM preventative interventions on health
parameters in the offspring beyond the neonatal period [9], and
very few for > 1 year [10].
As the number of hard endpoints in childhood is extremely
small, intermediate outcomes and surrogate markers are generally
used to assess paediatric health trajectories. Many have even tried
to define a paediatric clustering of risk factors equivalent to adult
metabolic syndrome (MetS). Although it is generally accepted that
the key components of paediatric MetS are abdominal obesity,
elevated fasting glucose, insulin resistance, abnormal lipid profile
and high blood pressure, establishing a clear-cut definition has
proved difficult. Thus, a number of different definitions of
paediatric MetS have been proposed, but met with a lack of
consensus as to which one to use. Furthermore, paediatric MetS
displays major instability from childhood to adolescence and
adulthood and therefore lacks reliable predictive value regardless
of the definition used [11]. Nevertheless, clusters of metabolic
abnormalities in childhood do arise, with the prevalence of
paediatric MetS reaching 3–39%, depending on the population
assessed and defining criteria applied [12,13]. In addition, the
association of childhood metabolic abnormalities with adult health
risk factors is well established [14,15].
Thus, the present study was designed to assess paediatric
metabolic health by analyzing its generally accepted key
components both separately and together as a calculated average,
based on previous publications [16–19]. In particular, the purpose
of this study was to assess the effect of a maternal lifestyle
intervention aiming to reduce the development of GDM in high-
risk women before, during and after pregnancy on the metabolic
health of the offspring at around 5 years after delivery.
Material and methods
Study design
This was a secondary analysis and follow-up study of women
and their offspring participating in the Finnish gestational diabetes
prevention study (RADIEL), a prospective cohort study conducted in
the cities of Helsinki and Lappeenranta between 2013 and 2017. The
original RADIEL (2008–2014) was a lifestyle interventional trial
aiming to reduce GDM development in high-risk women at three
maternity hospitals in the Helsinki metropolitan area (Helsinki
University Hospital, Kätilöopisto Maternity Hospital, Jorvi Hospital)
and at the South Karelia Central Hospital in Lappeenranta [20]. A
total of 720 women were recruited before or during early pregnancy
and randomized to either an interventional or conventional
(control) study group. The intervention was based on structured
counselling on physical activity and diet during visits.
The study protocol included visits to a study nurse every
trimester during pregnancy, as well as at 6 weeks, 6 months and
12 months after delivery, for all participants. In addition, the
women who were enrolled before pregnancy visited the study
nurse every 3 months until pregnancy. At each study visit, theparticipants filled in questionnaires, underwent physical exami-
nation including anthropometric and blood pressure measure-
ments, and had blood samples taken.
In addition to the study protocol, participants in both study arms
received antenatal healthcare provided by the public healthcare
system, according to Finnish standard practice. At the time of the
trial, conventional care during pregnancy consisted of 10–15 visits
to a nurse and two or three appointments with a physician.
Intervention group
During visits by women in the intervention group, trained study
nurses and nutritionists gave them structured counselling on
exercise and diet. Those enrolled in the prepregnancy period with a
prepregnancy body mass index (BMI)  25 kg/m2 were recom-
mended to lose 5–10% of their body weight prior to conception.
Women with a prepregnancy BMI  30 kg/m2 were recommended
to gain no weight during the first two trimesters of pregnancy.
Advice on diet was given according to the Finnish national
nutrition guidelines and Nordic Nutrition Recommendations
[21,22]. To achieve their goals, women in the intervention group
were advised to increase their intake of vegetables, legumes, fruits,
berries, fibre and wholegrain products, vegetable fats and low-fat
dairy, and to avoid sugar-rich foods. Also, structured counselling
was offered to each individual participant by study nurses.
Additional dietary advice was given only at the time of enrolment
by a nutritionist during a 2-h session in groups of 6–8 participants.
The goal of the physical-activity intervention was to achieve at
least 150 min/week of exercise at moderate intensity. This was
defined as any form of physical activity during which the participant
becomes slightly out of breath and is sweating, but is still able to talk.
In addition, all of the women were encouraged to promote exercise
during their daily commutes and/or in conjunction with everyday
household tasks, and to maintain physically active lifestyles. To this
end, the participants were offered free guided-exercise sessions once
a week and free entry tickets to public swimming facilities. Moreover,
each participant had to devise an individual exercise plan assisted by
the study nurse during the first study visit. This plan was then
modified if necessary during subsequent visits.
Control group
Study visits by participants in the conventional care (control)
group followed the same time schedule as the intervention group,
and their visits usually lasted half an hour. At the first visit, these
women received information leaflets on diet and exercise during
pregnancy similar to those provided at maternity clinics.
The methodological details of the original RADIEL have been
published previously elsewhere [20]. Every participant entered the
RADIEL voluntarily and gave their informed consent to participate.
The study complied with the Declaration of Helsinki and received
approval by the ethics committees of Helsinki University Hospital
(14 September 2006, Dnro 300/E9/06) and South Karelia Central
Hospital (11 September 2008, Dnro M06/08). The RADIEL was
registered at ClinicalTrials.gov (IDr: NCT01698385).
Participants
For the original RADIEL, women with a history of GDM and/or a
prepregnancy BMI  30 kg/m2 were recruited while either plan-
ning a pregnancy or during early pregnancy (< 20  0 weeks of
gestation). Exclusion criteria were age < 18 years, multiple pregnan-
cy, diabetes diagnosed before pregnancy, use of regular medication
affecting glucose metabolism, physical disability, severe psychiatric
disorder, current substance abuse and difficulty cooperating due to
inadequate language skills.
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study visit during pregnancy were eligible for an invitation to the
5-year follow-up substudy including their offspring (n = 607). Of
these, 595 mother–child dyads were approached, resulting in a
total of 332 dyads attending the follow-up visit 4–7 years after
delivery. On analyzing offspring metabolic health parameters,
children lacking more than one of the components used to assess
metabolic health were excluded, leaving a final total number of
263 participating dyads (Fig. 1).
Measurements
The follow-up study visit included blood sampling, and
anthropometric and blood pressure measurements. Blood was
drawn after approximately 4 h of fasting. Methods used for the
laboratory analyses have been previously published elsewhere
[23]. Duplicate waist-circumference (WC) measurements were
taken in the horizontal plane midway between the lowest rib and
iliac crest to the nearest 0.1 cm. Triplicate blood pressure
measurements of the right arm were taken in sitting position
with a sphygmomanometer (Intellisense M6 W, Omron Corpora-
tion, Kyoto, Japan). Mean arterial pressure (MAP) was calculated
using the formula MAP = diastolic blood pressure + (systolic blood
pressure–diastolic blood pressure)  1/3. BMI-for-age Z-scores
were calculated according to World Health Organization (WHO)
recommendations [24]. To assess body composition, a multifre-
quency electrical bioimpedance measurement method was used
(InBody 720/InBody 3.0, Biospace Co., Ltd, Seoul, Korea).
GDM was diagnosed according to national recommendations at
the time, using one or more pathological glucose values based on the
threshold levels recommended by the American Diabetes Association
(ADA) in 2008: fasting plasma glucose (FPG)  5.3 mmol/L; 1-h
glucose  10.0 mmol/L; and 2-h glucose  8.6 mmol/L [25]. All
women also underwent a 75-g 2-h oral glucose tolerance test
(OGTT) at 12–16 weeks of gestation. In cases of normal results, the
OGTT was repeated at 24–28 weeks of gestation unless treatment forFig. 1. Flow chart of the present substudy.GDM had been initiated. The 75-g 2-h OGTT is the standard
diagnostic test for GDM in Finland and similar to the ADA one-step
strategy, but different from the ADA two-step strategy, which uses a
100-g OGTT [26]. After a diagnosis of GDM, lifestyle management was
initiated. Pharmacological treatment was added in cases where FPG
levels were repeatedly > 5.5 mmol/L or > 7.8 mmol/L at 1 h post-
prandially [27]. Gestational weight gain was estimated by calculating
the difference between weight during the third trimester [measured
during the study visit at 35.1  1.1 standard deviation (SD) weeks of
pregnancy or, in cases of participants not attending the study visit, at the
corresponding visit to an antenatal clinic] and the self-reported
prepregnancy weight or weight measured at the last study visit prior
to pregnancy. Data on alcohol consumption, smoking and education
levels (in years) were self-reported.
Outcomes
The main outcome investigated in this substudy was offspring
metabolic health, as assessed through the total metabolic
parameter comprising age- and gender-standardized residuals of
WC, MAP, fasting insulin/glucose ratio, and inverted high-density
lipoprotein (HDL) cholesterol (1/HDL) and triglyceride (TG)
concentrations. Secondary outcomes were body fat mass and
body fat percentages in the offspring.
Statistics
Data are presented as means  SD with 95% confidence intervals
(CI), as medians with interquartile range (IQR) or as numbers with
percentages. Also, for this substudy, it was decided to use data
obtained during the first-trimester visit as baseline for all partici-
pants. Unpaired t and chi-squared tests were used to compare
baseline characteristics between the two study groups (intervention
vs. controls) as well as those included or lost to the 5-year follow-up.
For measurements of WC, MAP, fasting insulin/glucose ratio, 1/HDL
cholesterol, TG, alanine aminotransferase (ALT) and high-sensitivity
C-reactive protein (hs-CRP), linear regression analyses were first
applied to calculate the age- and gender-standardized residuals of the
study population. Then, to assess the accumulation of metabolic
health parameters within each given individual, the means of
standardized WC, MAP, fasting insulin/glucose ratio, 1/HDL choles-
terol and TG were also calculated. These variables were chosen to
comprise the total metabolic parameter based on previous published
research [16–19]. An unpaired t test was also applied to compare
offspring metabolic health parameters, ALT, hs-CRP and body
composition between intervention and control mothers. In cases of
violations of assumptions (non-normality), a bootstrap-type test was
applied. For sensitivity analyses, stratified primary outcome (total
metabolic health) analyses were performed according to offspring
gender, randomization timing (before pregnancy vs. early pregnancy)
and GDM presence or absence during the index pregnancy. Moreover,
linear regression analyses were used to adjust the primary analyses
with possible covariates [prepregnancy BMI, homoeostasis model
assessment of insulin resistance (HOMA-IR) at baseline, recruitment
time point, intervention group, number of previous children].
P < 0.05 was set as the threshold for statistical significance, and all
analyses were performed with Stata/SE version 14.2 and 15.1 software
(StataCorp, College Station, TX, USA).
Results
Maternal characteristics
At the first trimester visit, there were no differences in maternal
demographic data or clinical characteristics between the two study
groups (Table 1). However, differences in these baseline data were
Table 1
First-trimester maternal demographic and clinical characteristics by interventional or conventional care (control) group.
Characteristics Control (n = 137) Intervention (n = 126) P
Randomization before pregnancy 34 [25] 38 [30] 0.33
Gestational age (weeks) 13 (1.7) 13 (2.0) 0.60
Age (years) 33 (5) 33 (4) 0.54
Prepregnancy
Body weight (kg) 84 (17) 86 (18) 0.67
Body mass index (kg/m2) 30.7 (5.6) 30.9 (6.0) 0.82
Education level (years) 14 (2.2) 14 (1.9) 0.93
Previous children 0.52
None 42 [31] 31 [25]
1 64 [47] 62 [49]
2+ 31 [23] 33 [26]
Previous GDM 69 [50] 69 [55] 0.33
Blood pressure (mmHg)
Systolic 119 (13) 121 (12) 0.17
Diastolic 77 (9) 76 (9) 0.94
Total cholesterol (mmol/L) 4.8 (0.9) 4.9 (0.9) 0.08
HDL cholesterol (mmol/L) 1.6 (0.3) 1.7 (0.3) 0.19
Total triglycerides (mmol/L) 1.3 (0.5) 1.3 (0.5) 0.31
Fasting glucose (mmol/L) 5.1 (0.4) 5.0 (0.4) 0.71
Insulin (mU/L) 8.4 (5.4) 8.4 (5.1) 0.99
HOMA-IR 1.8 (1.1) 1.9 (1.3) 0.66
Smoking 7 [5] 5 [4] 0.67
Alcohol use 5 [4] 5 [4] 0.92
Dietary index score (points) 10 (3) 11 (3) 0.14
Physical activity (min/week), median (IQR) 60 (30, 120) 75 (30, 140) 0.58
GDM during index pregnancy 67 [49] 60 [48] 0.84
GDM treated with insulin 13 [9.5] 20 [16] 0.12
Data are presented as means (standard deviation, SD) or as numbers [%] unless otherwise stated; GDM: gestational diabetes mellitus; HDL: high-density lipoprotein; HOMA-
IR: homoeostasis model assessment of insulin resistance; IQR: interquartile range.
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those who were lost to follow-up. In the intervention group, the
mean age of non-attending mothers was lower by 1.4 years (95%
CI: 0.3–2.5; P = 0.01) vs. those attending. In addition, among the
non-attenders, the proportion of mothers recruited before
pregnancy was significantly lower (14%) than among the attenders
(30%; P = 0.001). In the control group, non-attending mothers
differed from attending mothers only by having higher mean levels
of HDL cholesterol (0.11, 95% CI: 0.02–0.19; P = 0.01).
Overall, the proportion of women who developed GDM in our
substudy was 48.5%. In the intervention group, 49.2% were
diagnosed with GDM (P = 0.79) vs. 47.6% in the control group.
Also, mean gestational weight gain did not differ between these
groups (P = 0.79).
Offspring metabolic health parameters
The children attending the follow-up visit were aged 4–7 years
(mean age: 5.1  0.5 years). An association was detected between
the intervention and offspring metabolic health, with more unfavou-
rable metabolic components observed in the offspring of women in
the intervention group (Fig. 2). The mean  SD value of the total
metabolic parameter was 0.09  0.63 in the intervention group and -
0.08  0.46 in the controls (P = 0.014). Differences in metabolic
component values between the two groups were related to glucose
and lipid metabolism and, specifically, to 1/HDL and TG concen-
trations (Fig. 2). Further analyses also suggested that the association
of the intervention with poorer metabolic outcomes was male-
specific (Fig. 3): the mean  SD value among boys from the
intervention group was 0.15  0.60, whereas the corresponding
value in the control group was 0.13  0.40 (P = 0.001).
Body composition and inflammatory markers
There was no difference between the two study groups
regarding offspring body composition and BMI-for-age Z-scores(Table 2). Also, age- and gender-standardized values of ALT did not
differ significantly between the groups, with a Z-score of
0.03  1.13 in the intervention group and 0.03  0.87 in the control
group (P = 0.60). Likewise, the age- and gender-standardized values of
hs-CRP were similar in both groups, with a Z-score of 0.1  1.23 in the
intervention group and 0.09  0.73 in the controls (P = 1.14).
Sensitivity analyses
A set of sensitivity analyses related to metabolic health
parameters was also performed. First, the offspring were stratified
according to maternal GDM status (Fig. 4). Among the offspring of
GDM pregnancies, the mean  SD value of the total metabolic
parameter in the intervention group was 0.13  0.58 vs.
0.11  0.43 in the control group (P = 0.01). Among the offspring
of non-GDM pregnancies, the tendency was similar but non-
significant (P = 0.35). In addition, no significant differences were
detected between the offspring of women diagnosed with GDM
during early pregnancy vs. those diagnosed with GDM during their
second trimester.
Second, when offspring were stratified according to timing of
randomization (before vs. early pregnancy), a tendency towards
poorer offspring metabolic health was detected in the intervention
arms of both these subgroups. However, the between-group
difference was significant only in the offspring of women recruited
during early pregnancy (P = 0.031), and not in the offspring of
women recruited before pregnancy (P = 0.28). It should be
emphasized that the percentage of women recruited before
pregnancy was only 27% (n = 72) of all participants included in
this substudy.
Finally, our main findings were adjusted for several possible
covariates. The detected between-group difference in offspring
metabolic health remained significant even after adjusting for
prepregnancy BMI, HOMA-IR at baseline, recruitment time point,
intervention group and number of previous children. In this
general linear model, only prepregnancy BMI and randomization
Fig. 2. Age- and gender-standardized residuals of metabolic health components in offspring at the 5-year follow-up visit by study group. Total: average of all components;
WC: waist circumference; MAP: mean arterial pressure; 1/HDL: inverted high-density lipoprotein concentration; TG: triglycerides; Insulin/Glucose: fasting insulin/glucose
ratio. Bars represent the confidence interval (CI).
Fig. 3. Age- and gender-standardized residuals of metabolic health components in offspring at the 5-year follow-up visit by intervention group and offspring gender. Total:
average of all components; WC: waist circumference; MAP: mean arterial pressure; 1/HDL: inverted high-density lipoprotein concentration; TG: triglycerides; Insulin/
Glucose: fasting insulin/glucose ratio. Bars represent the confidence interval (CI).
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were associated with poorer metabolic health in the offspring.
Discussion
The aim of the present substudy was to evaluate the effect of a
lifestyle intervention starting before or during early pregnancy and
ending 1 year after delivery on offspring metabolic health at
around 5 years of age. In fact, no positive effects of the lifestyle
intervention on either metabolic health or body composition were
detected in the offspring. More disturbing, given the results of this
study, a lifestyle intervention applied before, during and after
pregnancy might even have adverse effects on offspring metabolic
health outcomes. Such adverse effects were related to offspringglucose and lipid metabolism and, more specifically, to levels of
HDL cholesterol and TG. Moreover, these effects were more
pronounced in boys and in the offspring of GDM pregnancies.
However, these results need to be interpreted with care, and the
reasons behind them can only be speculated. The intervention was
relatively modest and may not have been intensive enough to have
any impact on offspring outcomes. Another explanation is the high
standard of the usual antenatal care in Finland, thereby resulting in
only small differences in management protocols between the
intervention and control groups. Finally, variations in offspring
metabolic health could depend, to a much greater extent, on
genetic variances than on intrauterine conditions, as previously
reported by Richmond et al. [28], who looked at the association of
maternal BMI in pregnancy with offspring adiposity in childhood
and adolescence.
Table 2
Offspring outcomes by study interventional or conventional care (control) group.
Characteristics Control (n = 137) Intervention (n = 126) P
Offspring birth weight (g) 3663 (507) 3685 (558) 0.75
Offspring standardized birth weight (g) 0.2 (1) 0.3 (1) 0.28
Age at follow-up visit (years) 5.1 (0.54) 5.5 (0.48) 0.69
Gender of offspring: 0.90
Girls 62 [45] 58 [46]
Boys 75 [55] 68 [54]
Waist circumference (cm) 54.7 (4.2) 54.9 (4.4) 0.77
Mean arterial pressure (mmHg) 75 (5.8) 74 (5.7) 0.45
Fasting insulin/glucose ratio 1.0 (0.97) 1.4 (1.54) 0.05
HDL cholesterol (mmol/L) 1.6 (0.31) 1.5 (0.28) 0.01
Triglycerides (mmol/L) 0.74 (0.30) 0.87 (0.50) 0.01
Alanine aminotransferase (U/L) 19 (6.9) 19 (9.0) 0.60
hs-CRP (mg/L) 0.49 (0.83) 0.71 (1.44) 0.13
Total metabolic parameters 0.08 (0.46) 0.09 (0.63) 0.01
Body composition (n = 121) (n = 106)
Fat-free mass (kg) 17 (2.3) 17 (2.4) 0.40
Boys 17 (2.4) 17 (2.5) 0.96
Girls 17 (2.1) 16 (2.2) 0.19
Fat mass (kg) 3.6 (1.7) 3.7 (1.8) 0.77
Boys 3.2 (1.5) 3.5 (1.8) 0.29
Girls 4.2 (1.8) 3.9 (1.9) 0.43
Fat percentage (%) 17 (6.1) 17 (6.2) 0.71
Boys 15 (5.9) 16 (5.8) 0.37
Girls 19 (5.6) 19 (6.3) 0.52
BMI-for-age (Z-score) 0.66 (0.80) 0.61 (1.0) 0.67
Boys 0.63 (0.81) 0.58 (1.1) 0.75
Girls 0.69 (0.78) 0.64 (1.0) 0.78
Data are presented as means (standard deviation, SD) or as numbers [%]; HDL: high-density lipoprotein; hs-CRP: high-sensitivity C-reactive protein; BMI: body mass index.
Fig. 4. Age- and gender-standardized residuals of metabolic health components in offspring at the 5-year follow-up visit by intervention group and maternal gestational
diabetes mellitus (GDM) status (: without; + with). Total: average of all components; WC: waist circumference; MAP: mean arterial pressure; 1/HDL: inverted high-density
lipoprotein concentration; TG: triglycerides; Insulin/Glucose: fasting insulin/glucose ratio. Bars represent the confidence interval (CI).
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intervention were detected. This was not surprising, as previous
studies have shown gender differences in fetal programming
patterns, such that differences in response to various kinds of
exposure during early fetal development may at least partly
explain gender-related health differences in adult life [29]. How-
ever, the specific mechanisms explaining such gender differences
in the developmental programming of metabolic health clearly
warrant further research.
Initially, it was speculated that greater offspring body size and
degrees of adiposity might explain the detected clustering of
unfavourable metabolic components related to glucose regulation
and lipid metabolism among the offspring of women in the
intervention group. However, it appears that offspring body size, asmeasured by WC and BMI-for-age, and body composition, as
measured by body fat mass and body fat percentage, were
unaffected by the intervention.
Another possible explanation could be related to
offspring liver metabolism, as previous studies have revealed
that impaired glucose metabolism and dyslipidaemia in child-
hood are comorbidities of paediatric non-alcoholic fatty liver
disease (NAFLD), a condition currently growing in incidence
[30]. Nevertheless, as liver biopsy, the gold standard for
diagnosing  NAFLD, is neither feasibly nor ethically performed
in healthy children, levels of ALT are commonly used as a proxy
measure. Yet, in this substudy, analyses of ALT and hs-CRP did not
add to clarification of the underlying pathological mechanisms of
our findings.
N.E. Grotenfelt et al. / Diabetes & Metabolism 46 (2020) 46–5352Offspring exposed to GDM in utero display higher rates of
overweight or obesity [31,32], impaired glucose metabolism [33],
type 2 diabetes [34], hypertension [35] and MetS [36,37] later in
life. In our substudy, however, GDM could not explain the
differences in offspring metabolic health between groups as a
whole. In our study population, a very small percentage of women
had severe GDM, as reflected by the low rate of medical treatment
(data not shown). In addition, participants with GDM were well
monitored in both study groups, thereby minimizing the adverse
effects of GDM on offspring. Interestingly, aggravation of the
unfavourable effects of the intervention was detected among the
offspring of women diagnosed with GDM, although the timing of
GDM diagnosis did not affect our findings. Furthermore, the
positive association of maternal prepregnancy BMI with poorer
offspring metabolic health was anticipated and in line with
previous studies [38,39].
Study limitations
One limitation of our substudy was the high rate of those lost to
follow-up, potentially making conclusions on the long-term effects
of GDM prevention on offspring health less reliable. However, our
dropout rate was no higher than the rates (20–65%) observed in
previous similar trials with long-term follow-ups of offspring
[9]. In our present study, 55% of the eligible mother–child dyads
attended the 5-year follow-up visit.
Analyses of the baseline data for mothers in the intervention
group whose children were lost to follow-up revealed a lower
mean age and smaller percentage enrolled before pregnancy
compared with women whose offspring attended the follow-up.
Likewise, in the control group, there was a difference in HDL
concentration between mothers of attenders and mothers of non-
attenders. These differences may have influenced our results, as
maternal cholesterol levels could act as mediators of the effects of
the intervention on offspring metabolic health.
Incomplete data on offspring body composition is another
limitation of our study. In addition, the offspring fasting time
before blood samples were drawn was self-reported, and even
though most participants reported a 4-h fast, there was nonethe-
less a variance of 2–4 h. Furthermore, it would be of considerable
interest to investigate the physical-activity levels and dietary
patterns of offspring at the 5-year follow-up time point, as these
are possible mediators of our results and could serve as secondary
outcomes. Indeed, our plan is to present these data in future.
Unfortunately, the power of our study was insufficient for
analyses of differences in offspring outcomes according to
intervention starting point. According to previous studies of fetal
programming, the timing of events is important, with the
periconceptional period being the most vulnerable [40]. Thus, it
would be of major interest to assess whether an intervention
starting well before pregnancy would have different effects on
offspring parameters compared with starting at the beginning of
pregnancy.
Conclusion
The lifestyle intervention aimed at reducing diagnoses of GDM
was not associated with favourable metabolic parameters of the
offspring at the 5-year follow-up. On the contrary, a less optimal
metabolic profile was observed among the offspring of women in
the intervention group. This finding was more pronounced in boys
and in the offspring of women diagnosed with GDM. Thus, our
present findings highlight the delicacy required to plan and
execute antenatal lifestyle interventions, and also emphasize the
importance of analyzing offspring follow-up data when assessingtheir efficacy. Nevertheless, our present results do add further
knowledge to the ongoing search for means to curb the global
increase in the prevalence of non-communicable diseases.
Source of funding
The study was funded by the Ahokas Foundation, Finnish
foundation for cardiovascular disease, a special state subsidy for
health science research from Helsinki University Hospital,
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Heterogeneity of maternal characteristics and impact on gestational diabetes
(GDM) risk-Implications for universal GDM screening? Ann Med 2016;48:52–
8. http://dx.doi.org/10.3109/07853890.2015.1131328.
[24] WHO Multicentre Growth Reference Study Group. WHO child growth stan-
dards: methods and development: length/height-for-age, weight-for-age,
weight-for-length weight-for-height and body mass index-for-age: methods
and development. Geneva: World Health Organization; 2006.
[25] American Diabetes Association. Standards of medical care in diabetes–2008.
Diabetes Care 2008;31(Suppl 1):S12–54. http://dx.doi.org/10.2337/dc08-S012.
[26] American Diabetes Association. 2. Classification and diagnosis of diabetes:
standards of medical care in diabetes-2019. Diabetes Care 2019;42:S13–28.
http://dx.doi.org/10.2337/dc19-S002.
[27] Working Group set up by the Finnish Medical Society Duodecim the Medical
Advisory Board of the Finnish Diabetes Association and the Finnish Society of
Obstetrics and Gynecology. Gestational Diabetes, Current Care Guidelines.
HttpwwwTerveysporttiFixmediahoihoiPdf n.d. http://www.terveysportti.fi/
xmedia/hoi/hoi50068.pdf (accessed June 20, 2018).
[28] Richmond RC, Timpson NJ, Felix JF, Palmer T, Gaillard R, McMahon G, et al. Using
genetic variation to explore the causal effect of maternal pregnancy adiposity onfuture offspring adiposity: a mendelian randomisation study. PLoS Med
2017;14:e1002221. http://dx.doi.org/10.1371/journal.pmed.100221.
[29] Li S, Zhu Y, Yeung E, Chavarro JE, Yuan C, Field AE, et al. Offspring risk of obesity
in childhood, adolescence and adulthood in relation to gestational diabetes
mellitus: a sex-specific association. Int J Epidemiol 2017;46:1533–41. http://
dx.doi.org/10.1093/ije/dyx151.
[30] Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R, et al. NASPGHAN
clinical practice guideline for the diagnosis and treatment of nonalcoholic
fatty liver disease in children: recommendations from the expert committee
on NAFLD (ECON) and the north american society of pediatric gastroenterolo-
gy. Hepatology and nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr
2017;64:319–34. http://dx.doi.org/10.1097/MPG.0000000000001482.
[31] Kubo A, Ferrara A, Windham GC, Greenspan LC, Deardorff J, Hiatt RA, et al.
Maternal hyperglycemia during pregnancy predicts adiposity of the offspring.
Diabetes Care 2014;37:2996–3002. http://dx.doi.org/10.2337/dc14-1438.
[32] Lawlor DA, Lichtenstein P, Långström N. Association of maternal diabetes
mellitus in pregnancy with offspring adiposity into early adulthood: sibling
study in a prospective cohort of 280,866 men from 248,293 families. Circulation
2011;123:258–65. http://dx.doi.org/10.1161/CIRCULATIONAHA.110.980169.
[33] Patel N, Godfrey KM, Pasupathy D, Levin J, Flynn AC, Hayes L, et al. Infant
adiposity following a randomised controlled trial of a behavioural intervention
in obese pregnancy. Int J Obes (Lond) 2017;60:709. http://dx.doi.org/10.1038/
ijo.2017.44.
[34] Damm P. Future risk of diabetes in mother and child after gestational diabetes
mellitus. Int J Gynaecol Obstet 2009;104(Suppl 1):S25–6. http://dx.doi.org/
10.1016/j.ijgo.2008.11.025.
[35] Tam WH, Ma RCW, Ozaki R, Li AM, Chan MHM, Yuen LY, et al. In utero exposure
to maternal hyperglycemia increases childhood cardiometabolic risk in off-
spring. Diabetes Care 2017;40:679–86. http://dx.doi.org/10.2337/dc16-2397.
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